WICK Nasivin Nasal Spray

WICK Nasivin is a well-known nasal spray used for the relief of nasal congestion caused by colds or allergies. The product contains oxymetazoline hydrochloride, which works as a decongestant. The brand WICK (known as Vicks outside of Germany and Austria) has a long history in the pharmaceutical industry, particularly in the cold and flu relief segment.

Originally developed in the United States by Lunsford Richardson in the late 19th century, the Vicks brand became a global household name. In Germany, the brand is marketed under the name WICK. For many years, Nasivin was a staple product of the German pharmaceutical company Merck KGaA. However, in 2018, Procter & Gamble (P&G) acquired Merck’s consumer health business, bringing Nasivin under the P&G Personal Health Care portfolio.

Manufacturing for WICK Nasivin remains heavily centered in Europe, particularly Germany, to serve the local and international markets with high-quality pharmaceutical standards. Ownership by Procter & Gamble allows the brand to benefit from a vast global distribution network and extensive research facilities located in the United States and Europe.